文献速递功能神经外科

G2019S LRRK2帕金森病脑深部电刺激的临床特征与结局

Clinical profiles and outcomes of deep brain stimulation in G2019S LRRK2 Parkinson disease.
PubMed 文献 · J Neurosurg · 2021-11-19

该队列研究纳入2009至2017年87例LRRK2帕金森病患者(其中13例接受脑深部电刺激)和14例接受脑深部电刺激的特发性帕金森病患者,比较临床特征与运动结局。LRRK2组因严重异动症转诊手术的比例高于特发性组,STN和GPi靶点均有效。

要点

  • LRRK2帕金森病接受脑深部电刺激者较未接受者起病年龄更轻、病程更长、异动症更多、起病时手部震颤更少。
  • LRRK2组因严重异动症转诊手术的比例高于特发性组,因药物难治性震颤转诊的比例低于特发性组。
  • STN和GPi靶点均能有效抑制症状,GPi组无翻修或不良反应报告,STN组有2例翻修、1例报告抑郁。

核心结论

  • 转诊接受脑深部电刺激的LRRK2帕金森病患者具有起病年龄较早和异动症等略有不同的特征。
  • STN和GPi两个脑深部电刺激靶点均能有效抑制症状。
  • G2019S LRRK2帕金森病患者适合脑深部电刺激治疗,无论靶点如何均有良好的运动结局。
  • LRRK2脑深部电刺激患者病程更长且倾向于有更多异动症。
  • 异动症常作为脑深部电刺激手术适应症的触发因素。

研究设计与样本

  • 该研究为基于门诊的队列研究,患者来自西奈山贝斯以色列帕金森病研究遗传学数据库。
  • 队列包括87例LRRK2帕金森病患者(其中13例接受脑深部电刺激)和14例接受脑深部电刺激的特发性帕金森病患者,入组时间为2009年至2017年。
  • 比较了LRRK2帕金森病接受与未接受脑深部电刺激者、LRRK2与特发性帕金森病接受脑深部电刺激者、以及LRRK2帕金森病接受STN与GPi脑深部电刺激者之间的基线临床特征。
  • 评估了术前和术后的纵向运动评分(统一帕金森病评定量表第三部分)和药物使用情况。

主要发现

  • 与未接受脑深部电刺激的LRRK2帕金森病患者(n=74)相比,接受脑深部电刺激的LRRK2帕金森病患者(n=13)起病年龄显著更轻、病程更长、更可能有异动症、起病时手部震颤更少。
  • LRRK2帕金森病患者因严重异动症转诊手术的比例高于特发性帕金森病患者(11/13 [85%] vs 6/14 [43%],p=0.04)。
  • LRRK2帕金森病患者因药物难治性震颤转诊手术的比例低于特发性帕金森病患者(0/13 [0%] vs 6/14 [43%],p=0.02)。
  • 在LRRK2帕金森病患者中,STN和GPi脑深部电刺激靶点均有效,但两组样本量均小。
  • GPi脑深部电刺激组未报告翻修或不良反应,而接受STN脑深部电刺激的LRRK2帕金森病患者中有2例需要翻修,另有1例报告抑郁为刺激相关副作用。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • STN和GPi脑深部电刺激两组样本量均小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to evaluate clinical features and response to deep brain stimulation (DBS) in G2019S LRRK2-Parkinson disease (LRRK2-PD) and idiopathic PD (IPD). METHODS: The authors conducted a clinic-based cohort study of PD patients recruited from the Mount Sinai Beth Israel Genetics database of PD studies. The cohort included 87 participants with LRRK2-PD (13 who underwent DBS) and 14 DBS participants with IPD enrolled between 2009 and 2017. The baseline clinical features, including motor ratings and levodopa-equivalent daily dose (LEDD), were compared among LRRK2-PD patients with and without DBS, between LRRK2-PD with DBS and IPD with DBS, and between LRRK2-PD with subthalamic nucleus (STN) and internal segment of the globus pallidus (GPi) DBS. Longitudinal motor scores (Unified Parkinson's Disease Rating Scale-part III) and medication usage were also assessed pre- and postoperatively. RESULTS: Compared to LRRK2-PD without DBS (n = 74), the LRRK2-PD with DBS cohort (n = 13) had a significantly younger age of onset, longer disease duration, were more likely to have dyskinesia, and were less likely to experience hand tremor at disease onset. LRRK2-PD participants were also more likely to be referred for surgery because of severe dyskinesia (11/13 [85%] vs 6/14 [43%], p = 0.04) and were less likely to be referred for medically refractory tremor (0/13 [0%] vs 6/14 [43%], p = 0.02) than were IPD patients. Among LRRK2-PD patients, both STN-DBS and GPi-DBS targets were effective, although the sample size was small for both groups. There were no revisions or adverse effects reported in the GPi-DBS group, while 2 of the LRRK2-PD participants who underwent STN-DBS required revisions and a third reported depression as a stimulation-related side effect. Medication reduction favored the STN group. CONCLUSIONS: The LRRK2-PD cohort referred for DBS had a slightly different profile, including earlier age of onset and dyskinesia. Both the STN and GPi DBS targets were effective in symptom suppression. Patients with G2019S LRRK2 PD were well-suited for DBS therapy and had favorable motor outcomes regardless of the DBS target. LRRK2-DBS patients had longer disease durations and tended to have more dyskinesia. Dyskinesia commonly served as the trigger for DBS surgical candidacy. Medication-refractory tremor was not a common indication for surgery in the LRRK2 cohort.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Leaver K, Viser A, Kopell BH, et al. Clinical profiles and outcomes of deep brain stimulation in G2019S LRRK2 Parkinson disease. J Neurosurg. 2021. PMID: 34798606. doi:10.3171/2021.7.JNS21190

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。